EG&G/PE Corp.
This article was originally published in The Gray Sheet
Executive Summary
EG&G completes $425 mil. acquisition of PE's Analytical Instruments business and gains rights to the "Perkin-Elmer" brand name, PE Corp. reports June 1. Announced March 8, the deal consists of $275 mil. in cash and $150 mil. in EG&G debt bearing a 5% coupon having a one-year maturity ("The Gray Sheet" March 15, p. 4)
You may also be interested in...
PerkinElmer's $400 Mil. NEN Buy Highlights Build In Genomics M&A Activity
Acquisition of NEN Life Sciences from the private equity investment firm Genstar Capital LLC for approximately $400 mil. will expand PerkinElmer's life sciences business and broaden the company's functional genomics and high-throughput screening offerings.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.